Icatibant Acetate
Brand name: Icatibant
Rank #299 of 500 drugs by total cost
$38.4M
Total Cost
831
Total Claims
$38.4M
Total Cost
29
Prescribers
$46K
Cost per Claim
39
Beneficiaries
831
30-Day Fills
$1.3M
Avg Cost/Provider
29
Avg Claims/Provider
About Icatibant Acetate
Icatibant Acetate (sold as Icatibant) was prescribed 831 times by 29 Medicare Part D providers in 2023, costing the program $38.4M. At $46K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 296 | Spironolactone (Spironolactone) | $39.4M | 3,126,938 |
| 297 | Varenicline Tartrate (Varenicline Tartrate) | $38.8M | 87,274 |
| 298 | Propranolol Hcl (Propranolol Hcl) | $38.7M | 1,168,547 |
| 299 | Icatibant Acetate (Icatibant) | $38.4M | 831 |
| 300 | Dextroamphetamine/Amphetamine (Dextroamphetamine-Amphetamine) | $38.2M | 706,329 |
| 301 | Nebivolol Hcl (Nebivolol Hcl) | $38.2M | 421,756 |
| 302 | Cinacalcet Hcl (Cinacalcet Hcl) | $37.9M | 76,761 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology